Redken Laboratories Inc saidits board authorized management to repurchase up to 600,000 ofthe company's common shares.    The repurchase program may be implimented over the next 18months, or sooner, depending on whether or not the shares arebought in the open market or in privately negotiatedtransactions, Redken said.    The program will be funded with cash on hand and futurecash flow, the company also said. Reuter&#3;